Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy®醫學論壇網-網聚醫學的力量

Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy

作者：Zhipeng Sun1 and Nengwei Zhang2 來源：醫學論壇網日期：2017-11-15

導讀

Abstract Background: In the clinical practice of neoadjuvant chemotherapy, response markers are very important. We aimed o investigate whether tumor markers CEA(carcino-embryonic antigen), CA19-9(carbohydrate antigen 19–9), CA72-4(carbohydrate antigen 72

關鍵字： Gastric | cancer | | Neoadjuvant | chemotherapy | | CEA | | CA19-9 | | CA72-4 | | CA125

Abstract

Background: In the clinical practice of Neoadjuvant chemotherapy, response markers are very important. We aimed

o investigate whether tumor markers CEA(carcino-embryonic antigen), CA19-9(carbohydrate antigen 19–9), CA72-4

(carbohydrate antigen 72–4), and CA125(carbohydrate antigen 125) can be used to evaluate the response to

neoadjuvant chemotherapy, and to evaluate the diagnosis and prognosis value of four tumor markers in the patients of Gastric cancer.

閱讀全文請見：Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy

醫學教育